Apolipoprotein B deficient hepatoma cell line (VA)

ApoB CRISPR/Cas9 Knockout Huh7 Stable Cell Line
Technology No. HUS02-07

The ApoB CRISPR/Cas9 Knockout Huh7 Stable Cell Line is generated using CRISPR/Cas9 genome editing technology and features a stable knockout of Apolipoprotein B (ApoB) - a critical component of low-density lipoprotein (LDL) which plays a significant role in lipid metabolism and cardiovascular disease. This cell line is invaluable for researching ApoB's function in lipid transport, understanding the pathogenesis of atherosclerosis, and screening for potential lipid-lowering therapies.

  • expand_more mode_edit Authors (1)
    Mahmood Hussain, PhD
  • expand_more cloud_download Supporting documents (1)
    Product brochure
    Apolipoprotein B deficient hepatoma cell line (VA).pdf
    DOWNLOAD
Questions about this technology?
Contact us